2025
$1.96
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital (overstated 2023 by $309M and 2025 by $385M, the tax benefits booked on the intangible impairments); (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them (e.g. 2021). OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,525.3M; reported operating asset/liability changes=$-152.4M of which deferred tax=$-385.3M, so true WC change=$232.9M; SBC=$80.0M; capex=$84.3M, growth capex=$6.2M (capex ratio 1.996% x revenue increase; zero if revenue fell), maintenance capex=$78.1M; NCI income=$106.9M vs CIP non-cash (gains)/losses already removed in CFO=$67.9M, NCI cash share deducted=$39.0M (NCI income beyond CIP marks; rule: marks attributed to NCI up to its income when same sign); preferred dividends=$204.6M. OE=$890.7M; diluted shares=455.0M; OE/sh=$1.96. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-26-000079.
2024
$1.41
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,190.0M; reported operating asset/liability changes=$101.5M of which deferred tax=$-38.1M, so true WC change=$139.6M; SBC=$104.6M; capex=$69.1M, growth capex=$7.0M (capex ratio 1.996% x revenue increase; zero if revenue fell), maintenance capex=$62.1M; NCI income=$-22.4M vs CIP non-cash (gains)/losses already removed in CFO=$-57.9M, NCI cash share deducted=$0.0M (NCI income beyond CIP marks; rule: marks attributed to NCI up to its income when same sign); preferred dividends=$236.8M. OE=$646.9M; diluted shares=457.7M; OE/sh=$1.41. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-25-000114.
2023
$1.38
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital (overstated this year by $309M, the tax benefit on the $1,248.9M intangible impairment); (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,300.8M; reported operating asset/liability changes=$-154.4M of which deferred tax=$-309.2M, so true WC change=$154.8M; SBC=$114.6M; capex=$164.3M, growth capex=$0.0M (revenue fell), maintenance capex=$164.3M; NCI income=$-71.3M vs CIP non-cash (gains)/losses already removed in CFO=$-176.3M, NCI cash share deducted=$0.0M (NCI income beyond CIP marks; rule: marks attributed to NCI up to its income when same sign); preferred dividends=$236.8M. OE=$630.3M; diluted shares=456.2M; OE/sh=$1.38. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-24-000219.
2022
$2.11
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$703.2M; reported operating asset/liability changes=$-758.3M of which deferred tax=$48.3M, so true WC change=$-806.6M; SBC=$106.2M; capex=$192.9M, growth capex=$0.0M (revenue fell), maintenance capex=$192.9M; NCI income=$4.8M vs CIP non-cash (gains)/losses already removed in CFO=$-126.9M (opposite sign, so none attributed to NCI), NCI cash share deducted=$4.8M; preferred dividends=$236.8M. OE=$969.1M; diluted shares=459.5M; OE/sh=$2.11. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-23-000297 (CIP marks per FY2024 10-K 0000914208-25-000114).
2021
$2.81
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them (this year the earlier series deducted $339.6M of NCI income that was almost entirely non-cash CIP gains already excluded from CFO). OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,078.1M; reported operating asset/liability changes=$-622.1M of which deferred tax=$79.7M, so true WC change=$-701.8M; SBC=$140.1M; capex=$108.8M, growth capex=$15.0M (capex ratio 1.996% x revenue increase), maintenance capex=$93.8M; NCI income=$339.6M vs CIP non-cash gains already removed in CFO=$390.0M, NCI cash share deducted=$0.0M (NCI income beyond CIP marks; rule: marks attributed to NCI up to its income when same sign); preferred dividends=$236.8M. OE=$1,309.2M; diluted shares=465.4M; OE/sh=$2.81. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-22-000319.
2020
$1.32
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,230.3M; reported operating asset/liability changes=$146.6M of which deferred tax=$81.3M, so true WC change=$65.3M; SBC=$188.5M; capex=$115.0M, growth capex=$0.6M (capex ratio 1.996% x revenue increase), maintenance capex=$114.4M; NCI income=$45.9M vs CIP non-cash gains already removed in CFO=$32.1M, NCI cash share deducted=$13.8M (NCI income beyond CIP marks; rule: marks attributed to NCI up to its income when same sign); preferred dividends=$236.8M. OE=$611.5M; diluted shares=462.5M; OE/sh=$1.32. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-21-000331.
2019
$1.23
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,116.6M; reported operating asset/liability changes=$139.0M of which deferred tax=$22.1M, so true WC change=$116.9M; SBC=$207.5M; capex=$124.3M, growth capex=$16.0M (capex ratio 1.996% x revenue increase), maintenance capex=$108.3M; NCI income=$49.5M vs CIP non-cash gains already removed in CFO=$32.9M, NCI cash share deducted=$16.6M; preferred dividends=$123.6M (partial year; preferred issued May 2019 with the OppenheimerFunds acquisition). OE=$543.7M; diluted shares=440.5M; OE/sh=$1.23. Transition year (partial-year acquisition), excluded from anchor window. Cross-check: equals NI + D&A + impairments + deferred tax + other non-cash items - maintenance capex - NCI cash share - preferred dividends. Source: accession 0000914208-20-000245 (figures confirmed in FY2021 10-K comparatives 0000914208-22-000319).
2018
$2.51
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$828.8M; reported operating asset/liability changes=$-439.3M of which deferred tax=$37.5M, so true WC change=$-476.8M; SBC=$172.4M; capex=$102.5M, growth capex=$3.1M (capex ratio 1.996% x revenue increase), maintenance capex=$99.4M; NCI income=$0.3M vs CIP non-cash losses already removed in CFO=$-55.1M (opposite sign, none attributed to NCI), NCI cash share deducted=$0.3M; no preferred outstanding. OE=$1,033.5M; diluted shares=412.5M; OE/sh=$2.51. Cross-check: equals NI + D&A + deferred tax + other non-cash items - maintenance capex - NCI cash share. Source: accession 0000914208-19-000195.
2017
$2.38
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital (here the $51.7M deferred tax benefit, largely the 2017 US tax-reform remeasurement, is non-cash and now excluded); (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$1,157.8M (restated, per FY2018 10-K comparative; originally $1,370.7M); reported operating asset/liability changes=$-146.3M of which deferred tax=$-51.7M, so true WC change=$-94.6M; SBC=$175.3M; capex=$111.7M, growth capex=$8.5M (capex ratio 1.996% x revenue increase), maintenance capex=$103.2M; NCI income=$33.7M vs CIP non-cash gains already removed in CFO=$81.0M, NCI cash share deducted=$0.0M; no preferred outstanding. OE=$973.9M; diluted shares=409.9M; OE/sh=$2.38. Cross-check: equals NI + D&A + deferred tax + other non-cash items - maintenance capex - NCI cash share. Source: accession 0000914208-19-000195 (FY2018 10-K comparative; originally 0000914208-18-000255).
2016
$1.99
▼
Recomputed 2026-09-28 (whole series) to correct two basis errors and use the latest restated figures: (a) Invesco's cash-flow reconciliation has no separate deferred-tax line - deferred tax sits inside the receivables/payables changes, so the earlier series wrongly stripped it as working capital; (b) CFO already removes non-cash gains/losses of consolidated investment products (CIP), so deducting all NCI income double-counted them; (c) CFO and working capital now taken from the restated FY2018 10-K comparatives. OE = CFO - true working-capital change - SBC - maintenance capex - NCI cash share - preferred dividends. CFO=$654.0M (restated; originally $129.3M, the difference being CIP classification); reported operating asset/liability changes=$-468.5M of which deferred tax=$15.4M, so true WC change=$-483.9M; SBC=$159.7M; capex=$147.7M, growth capex=$0.0M (revenue fell), maintenance capex=$147.7M; NCI income=$14.1M vs CIP non-cash gains already removed in CFO=$7.4M, NCI cash share deducted=$6.7M; no preferred outstanding. OE=$823.8M; diluted shares=415.0M; OE/sh=$1.99. Cross-check: equals NI + D&A + deferred tax + other non-cash items - maintenance capex - NCI cash share. Source: accession 0000914208-19-000195 (FY2018 10-K restated comparatives; originally FY2016 10-K 0000914208-17-000328).
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.